It has been recently shown that MSI-H cancers often contain BRCA1/2 mutations; however, these mutations are predominantly monoallelic and are considered bystander alterations because they are not associated with gLOH and did not confer PARP sensitivity in several patients66. Here, BRCA1 is linked to cancer.